Diabetes drugs associated with fewer adverse cardiac events in older veterans: study

GLP1 receptor agonists — a class of diabetes medications — are associated with fewer major adverse cardiovascular events than another type of diabetes drug (DPP4 inhibitors) in older veterans with no prior heart disease. The findings, reported May 9 in Annals of Internal Medicine, will aid clinicians in choosing a diabetes...

Read more...

Ozempic Semaglutide

This document is a summary of the European Public Assessment Report (EPAR) for Ozempic.It explains how the Agency's evaluation of the medicinal product led it to recommend its authorisation in the EU and its conditions of use.recommended its authorisation in the EU and its conditions of use. It is not...

Read more...
You've just added this product to the cart: